Candida in burns: Risk factors and outcomes

Journal of Burn Care and Research

Volumn 31, Issue 2, 2010, Pages 257-263

  Moore, Edwina C ^a   Padiglione, Alexander A ^a   Wasiak, Jason ^a,b   Paul, Eldho ^b   Cleland, Heather ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMIKACIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFAZOLIN; CEFEPIME; CEFTRIAXONE; CLAVULANIC ACID; COTRIMOXAZOLE; FLUCONAZOLE; GENTAMICIN; NYSTATIN; PSEUDOMONIC ACID; SULFADIAZINE SILVER; TICACILLIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; ARTICLE; AUSTRALIA; BURN; BURN INFECTION; BURN UNIT; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CLINICAL PROTOCOL; DRUG EXPOSURE; ETHICS; FEMALE; FULL THICKNESS SKIN GRAFT; FUNGAL COLONIZATION; FUNGUS CULTURE; FUNGUS ISOLATION; HOSPITAL ADMISSION; HUMAN; INFECTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; NONHUMAN; OPERATING ROOM; OUTCOME ASSESSMENT; PREDICTION; PROPHYLAXIS; RISK FACTOR; SEPSIS; THRUSH; TOTAL PARENTERAL NUTRITION; WOUND INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; BURNS; CANDIDA; CANDIDIASIS; CROSS INFECTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; VICTORIA;

EID: 77649318439     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3181d0f536     Document Type: Article

References (51)

1. Ballard J, Edelman L, Saffle J, et al. Positive fungal cultures in burn patients: a multicenter review. J Burn Care Res 2008; 29:213-221
2. Beck-Sague C, Banerjee S, Jarvis WR. Infectious diseases and mortality among US nursing home residents. Am J Public Health 1993;83:1739-1742
3. Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities: results of a populationbased active surveillance. Clin Infect Dis 1999;29:1164-1170
4. Dean DA, Burchard KW. Surgical perspective on invasive Candida infections. World J Surg 1998;22:127-134
5. Becker WK, Cioffi WG Jr, McManus AT, et al. Fungal burn wound infection. A 10-year experience. Arch Surg 1991;126: 44-48
6. Nash G, Foley FD, Goodwin MN Jr, Bruck HM, Greenwald KA, Pruitt BA Jr. Fungal burn wound infection. JAMA 1971; 215:1664-1666
7. Prasad JK, Feller I, Thomson PD. A ten-year review of Candida sepsis and mortality in burn patients. Surgery 1987;101: 213-216
8. Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the adaptive immune response. Shock 1999;11:153-159
9. Cochran A, Morris SE, Edelman LS, Saffle JR. Systemic Candida infection in burn patients: a case-control study of management patterns and outcomes. Surg Infect (Larchmt) 2002;3:367-374
10. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995;20: 1526-1530
11. Esposito S. Immune system and surgical site infection. J Chemother 2001;13:12-16
12. Vindenes H, Bjerknes R. Microbial colonization of large wounds. Burns 1995;21:575-579
13. Ekenna O, Sherertz RJ, Bingham H. Natural history of bloodstream infections in a burn patient population: the importance of candidemia. Am J Infect Control 1993;21: 189-195
14. Golan Y, Wolf MP, Pauker SG, Wong JB, Hadley S. Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. Ann Intern Med 2005;143:857-869
15. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 1988;148: 2642-2645
16. Eubanks PJ, de Virgilio C, Klein S, Bongard F. Candida sepsis in surgical patients. Am J Surg 1993;166:617-19; discussion 619-620
17. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15:414-421
18. Rentz AM, Halpern MT, Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 1998;27:781-788
19. Swoboda SM, Merz WG, Lipsetta PA. Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit. Surg Infect (Larchmt) 2003;4:345-354
20. Desai MH, Rutan RL, Heggers JP, Herndon DN. Candida infection with and without nystatin prophylaxis. A 11-year experience with patients with burn injury. Arch Surg 1992; 127:159-162
21. Schofield CM, Murray CK, Horvath EE, et al. Correlation of culture with histopathology in fungal burn wound colonization and infection. Burns 2007;33:341-346
22. Horvath EE, Murray CK, Vaughan GM, et al. Fungal wound infection (not colonization) is independently associated with mortality in burn patients. Ann Surg 2007;245:978-985
23. Santucci SG, Gobara S, Santos CR, Fontana C, Levin AS. Infections in a burn intensive care unit: experience of seven years. J Hosp Infect 2003;53:6-13.
24. Allen DM, Ang BS. The prevalence of invasive candidiasis in patients with extensive burns. Ann Acad Med Singapore 1992;21:656-659
25. Spebar MJ, Pruitt Jr BA. Candidiasis in the burned patient. J Trauma 1981;21:237-239
26. Sheridan RL, Weber JM, Budkevich LG, Tompkins RG. Candidemia in the pediatric patient with burns. J Burn Care Rehabil 1995;16:440-443
27. Vinsonneau C, Benyamina M, Baixench MT, et al. Effects of candidaemia on outcome of burns. Burns 2009;35:561-564
28. Borzotta AP, Beardsley K. Candida infections in critically ill trauma patients: a retrospective case-control study. Arch Surg 1999;134:657-64; discussion 664-665
29. Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001; 33:177-186
30. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751-758
31. Jones JM. Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev 1990;3:32-45.
32. Hodle AE, Richter KP, Thompson RM. Infection control practices in U.S. burn units. J Burn Care Res 2006;27: 142-151
33. Petri MG, König J, Moecke HP, et al. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 1997;23:317-325
34. MacMillan BG, Law EJ, Holder IA. Experience with Candida infections in the burn patient. Arch Surg 1972;104: 509-514
35. Still JM Jr, Belcher K, Law EJ. Management of Candida septicaemia in a regional burn unit. Burns 1995;21:594-596
36. Nasser S, Mabrouk A, Maher A. Colonization of burn wounds in Ain Shams University Burn Unit. Burns 2003;29: 229-233
37. Grube BJ, Marvin JA, Heimbach DM. Candida. A decreasing problem for the burned patient? Arch Surg 1988;123: 194-196
38. Murray CK, Loo FL, Hospenthal DR, et al. Incidence of systemic fungal infection and related mortality following severe burns. Burns 2008;34:1108-1112
39. Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000;30:662-678
40. Rex JH, Sobel JD. Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 2001;32:1191-1200
41. Sobel JD, Rex JH. Invasive candidiasis: turning risk into a practical prevention policy? Clin Infect Dis 2001;33:187-190
42. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004;38:161-189
43. Vincent JL, Anaissie E, Bruining H, et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998;24:206-216
44. Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party. Intensive Care Med 1994;20: 522-528
45. Chow JK, Golan Y, Ruthazer R, et al. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med 2008;36:1993-1998
46. Desai MH, Herndon DN, Abston S. Candida infection in massively burned patients. J Trauma 1987;27:1186-1188
47. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched casecontrol study. Arch Intern Med 1989;149:2349-2353
48. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005;49:3640-3645
49. Keen A, Knoblock L, Edelman L, Saffle J. Effective limitation of blood culture use in the burn unit. J Burn Care Rehabil 2002;23:183-189
50. Weinstein MP. Clinical importance of blood cultures. Clin Lab Med 1994;14:9-16.
51. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997;24:584-602.